Baby formula with HMO and DHA/ARA may sharpen infant cognition, study finds

NCT ID NCT06146387

Completed Knowledge-focused Sponsor: Heilongjiang Feihe Dairy Co. Ltd. Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This completed trial enrolled 240 healthy newborns to see if a formula containing HMO, DHA, and ARA improves cognitive scores at 12 months compared to a standard formula or breastfeeding. Babies were fed the assigned formula or breast milk for up to a year, and their thinking skills were measured using the Bayley-III test. The study aims to find out whether adding these nutrients to formula can support early brain development.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: infant formula with human milk oligosaccharides (HMO), DHA, and ARA
What this could lead to: If the formula shows better cognitive scores, it could support using specific nutrients in infant formula to aid early brain development.
What could go wrong: This is a single completed study with 240 infants, so results may not apply broadly. Cognitive tests at 12 months may not predict long-term intelligence.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COGNITIVE CHANGE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cognitive disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

COGNITIVE CHANGE

Contacts and locations

Locations

Jinhua Nanyuan Community Health Center (site 1919)

Jinhua, Zhejiang, China
Li Pu Community Hospital

Jinhua, Zhejiang, China
Qiu Bin Community Hospital

Jinhua, Zhejiang, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.